SLC2A3 and glioblastoma: Furthermore, we used clinical GBM samples and control samples for the immunohistochemical detection of the protein expression of seven prognostic genes at the protein level, except SLC2A3 (not quite significant at the protein level), all reaching the same conclusion as the public database (Figure 10A,B).